The Effect of Thyroid Lobe Volume on the Common Carotid Artery Blood Flow

January 22, 2025 updated by: Başar Erdivanlı, Recep Tayyip Erdogan University

The Effect of Thyroid Lobe Volume on the Common Carotid Artery Blood Flow in Thyroidectomy Position

The goal of this observational study is to evaluate how thyroid lobe volume affects carotid artery blood flow dynamics in adult patients undergoing elective thyroidectomy. The study includes male and female participants aged 18 years and older who have euthyroid function and are scheduled for elective thyroidectomy.

The main questions it aims to answer are:

  • Does thyroid lobe volume influence carotid artery blood flow characteristics, particularly systolic/diastolic flow time ratios, during thyroidectomy?
  • What is the optimal thyroid lobe volume cutoff for predicting altered systolic/diastolic flow time ratios (<0.3)?

Participants will:

  • Undergo Doppler ultrasound measurements at three time points: before anesthesia induction, after anesthesia induction, and after surgical positioning.
  • Have their carotid artery blood flow and regional cerebral oxygenation values assessed.

No comparison groups are involved, as all participants will be observed under the same conditions.

Study Overview

Detailed Description

This observational study investigates how the size of the thyroid gland affects blood flow in the common carotid artery during thyroidectomy, a surgical procedure to remove part or all of the thyroid gland. The thyroid gland is anatomically close to the carotid artery, a major blood vessel supplying blood to the brain. Enlarged thyroid lobes may compress the artery, potentially altering blood flow dynamics, particularly during the semi-Fowler's position required for the surgery. By examining these effects, this study aims to provide insights into the interplay between thyroid anatomy and carotid blood flow, which could have implications for surgical and anesthetic management.

Study Objectives

The primary objective is to determine the relationship between thyroid lobe volume and carotid artery blood flow during thyroidectomy. Specifically, the study seeks to:

  1. Evaluate how thyroid lobe volume influences systolic and diastolic blood flow in the carotid artery.
  2. Identify a thyroid lobe volume cutoff associated with significant alterations in systolic/diastolic flow time ratios (<0.3).

Study Population

The study includes adult patients aged 18 years and older scheduled for elective thyroidectomy. Participants must be in a euthyroid state, as thyroid hormone abnormalities may influence recovery and perioperative outcomes. Patients with conditions such as anemia, labile hypertension, or prior thyroid surgeries, as well as pregnant or emergency cases, are excluded.

Study Design

This is a prospective observational study conducted at a tertiary academic hospital. Measurements are obtained from each participant at three critical time points:

  1. Baseline (T0): Before anesthesia induction.
  2. After anesthesia induction (T1).
  3. After surgical positioning (T2): In the semi-Fowler's position with head extension.

Doppler ultrasound is used to assess carotid artery diameters and flow velocities. Regional cerebral oxygenation is also measured using a cerebral oximeter to evaluate the impact of altered blood flow on brain perfusion.

Study Methods

Participants undergo the following procedures during the study:

  • Ultrasound Measurements: The diameters of the common carotid artery at systole and diastole are measured, and Doppler flow velocities (peak systolic velocity, end-diastolic velocity) are recorded. These values are used to calculate mean velocity, Gosling pulsatility index, and Pourcelot resistance index.
  • Manual Tracing of VTI: In cases with altered systolic/diastolic flow ratios, manual tracing is used to ensure accuracy.

Study Type

Observational

Enrollment (Actual)

132

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rize, Turkey, 53020
        • Recep Tayyip Erdoğan University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population consists of adult patients scheduled for elective thyroidectomy at a tertiary academic hospital. Participants are drawn from the hospital's general surgery clinic, which serves a diverse population from both urban and surrounding rural areas. Patients undergoing surgery for various thyroid pathologies, including benign nodules and malign pathologies, are included. All participants are assessed preoperatively to ensure they meet the study's inclusion criteria, including euthyroid status, and are representative of individuals typically undergoing elective thyroid surgery in this clinical setting.

Description

Inclusion Criteria:

  • Adult patients (≥18 years old) scheduled for elective thyroidectomy.
  • Patients in a euthyroid state as confirmed by recent laboratory tests.
  • Ability to provide written informed consent.

Exclusion Criteria:

  • Pregnant patients.
  • Emergency thyroidectomy cases.
  • History of subtotal thyroidectomy.
  • History of allergic reaction to anesthetic agents.
  • Presence of anemia (hemoglobin levels below local institutional thresholds).
  • Presence of labile hypertension (documented by repeated measurements on the surgical ward)
  • Presence of abnormal thyroid hormone levels.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Normal size
Right or left side of any patient with a normal thyroid lobe size according to gender-specific limits of normal thyroid volume (15 ml for adult females, 18 ml for adult males)
Large size
Right or left side of any patient with a large thyroid lobe size according to gender-specific limits of normal thyroid volume (15 ml for adult females, 18 ml for adult males)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Systolic/Diastolic Flow Time Ratio of the Common Carotid Artery
Time Frame: Measured at baseline (T0), post-anesthesia induction (T1), and post-surgical positioning (T2).
Assess the relationship between thyroid lobe volume and alterations in the systolic/diastolic flow time ratio during thyroidectomy.
Measured at baseline (T0), post-anesthesia induction (T1), and post-surgical positioning (T2).
Thyroid Lobe Volume Cutoff for Altered Flow Dynamics
Time Frame: Post-hoc analysis using data from baseline (T0).
Determine the thyroid lobe volume cutoff associated with a systolic/diastolic flow time ratio <0.3.
Post-hoc analysis using data from baseline (T0).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Carotid Artery Blood Flow
Time Frame: Measured at baseline (T0), post-anesthesia induction (T1), and post-surgical positioning (T2).
Evaluate how thyroid lobe volume affects carotid artery blood flow during different surgical time points.
Measured at baseline (T0), post-anesthesia induction (T1), and post-surgical positioning (T2).
Regional Cerebral Oxygenation Changes
Time Frame: Measured at baseline (T0), post-anesthesia induction (T1), and post-surgical positioning (T2).
Measure the impact of altered carotid artery blood flow on regional cerebral oxygenation during thyroidectomy.
Measured at baseline (T0), post-anesthesia induction (T1), and post-surgical positioning (T2).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Başar Erdivanlı, Assoc. Prof., Recep Tayyip Erdogan University Medical Faculty

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 6, 2017

Primary Completion (Actual)

December 24, 2018

Study Completion (Actual)

March 20, 2020

Study Registration Dates

First Submitted

January 22, 2025

First Submitted That Met QC Criteria

January 22, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 22, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The raw data supporting the reported results and the R source files used during the analysis will be made available by the authors on reasonable request.

IPD Sharing Time Frame

The individual participant data (IPD) and supporting information, including the study protocol, statistical analysis plan, and analytic code, will be available starting 6 months after publication of the study results. Data will remain available indefinitely for academic purposes.

IPD Sharing Access Criteria

Access to the IPD and supporting information will be provided upon reasonable request to researchers affiliated with academic institutions. Requestors must provide proof of academic affiliation and a clear statement of their intended use of the data. Requests will be reviewed by the corresponding author to ensure alignment with the study's objectives and ethical considerations. Data will be shared through secure data transfer mechanisms.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Thyroid Surgery

Subscribe